The Bacteroides Fragilis Toxin Binds to a Specific Intestinal Epithelial Cell Receptor.
From: Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, 1550 Orleans St., Baltimore, MD 21231, USA.
Infection and immunity
- Publish Date: Sep 2006
- ISSN: 0019-9567
- Volume: 74
- Issue: 9
- Pages: 5382-90
- Medium: Print
- Language: English
- Citation (JAMA): Wu Shaoguang, Shin Jai, Zhang Guangming, et al. The Bacteroides Fragilis Toxin Binds to a Specific Intestinal Epithelial Cell Receptor.. Infect. Immun. Sep 2006;74:5382-90
Abstract
The Bacteroides fragilis toxin (BFT) is the only known virulence factor of enterotoxigenic B. fragilis. BFT has previously been shown to act, at least in part, through cleavage of the intercellular adhesion protein E-cadherin. A specific cellular receptor for BFT has not been identified. The goal of this study was to determine if the initial interaction of BFT with intestinal epithelial cells was consistent with binding to a specific cellular receptor. Purified BFT was labeled with a fluorophore or iodide to assess specific cellular binding and the properties of BFT cellular binding. BFT binds specifically to intestinal epithelial cell lines in vitro in a polarized manner. However, specific binding occurs only at 37 degrees C and requires BFT metalloprotease activity. The BFT receptor is predicted to be a membrane protein other than E-cadherin or a known protease-activated receptor (PAR1 to PAR4). BFT binding is resistant to acid washing, suggesting an irreversible interaction. Sugar or lipid residues do not appear to be involved in the mechanism of BFT cellular binding, but binding is sensitive to membrane cholesterol depletion. We conclude that intestinal epithelial cells in vitro possess a specific membrane BFT receptor that is distinct from E-cadherin. The data favor a model in which the metalloprotease domain of BFT processes its receptor protein, initiating cellular signal transduction that mediates the biological activity of BFT. However, activation of recognized protease-activated receptors does not mimic or block BFT biological activity or binding, suggesting that additional protease-activated receptors on intestinal epithelial cells remain to be identified.
Mesh Headings (Keywords): Bacterial Toxins, Cadherins, Cells, Cultured, Cholesterol, Dipeptides, Humans, Intestinal Mucosa, Membrane Microdomains, Metalloendopeptidases, Protease Inhibitors, Protein Structure, Tertiary, Receptors, Cell Surface, Receptors, Proteinase-Activated
Check for Full Text / PubMed Unique Identifier (PMID): 16926433
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.